Anaplastic Thyroid Cancer GUIDELINES Pocket Guide

Approved By

American Thyroid Association

Digital Subscription $4.99 Add to Cart
Print $11.95 Add to Cart
Free Sample

The digital subscription version of the Anaplastic Thyroid Cancer GUIDELINES Pocket Guide contains all the same great information found in the physical pocket guide, and can be accessed on mobile devices and online:

  • Price: $4.99 per year
    • Subscribe to additional guideline titles for discounted rates
  • Includes automatic updates during the term of your subscription
  • CPT® and ICD10 codes can be added to certain guidelines for an additional fee
  • Supported platforms
    • iPhone and iPad
    • Android phones and tablets
    • Online (internet connection required)
  • Content on the Guideline Central mobile app accessible without an internet connection
    • Access to additional guideline summaries, clinical calculators, and more

For mobile access, download the free app from the App Store or Google Play and use the same email address and password as the website to login.

For individual use only; contact us for group and site licenses.

The Anaplastic Thyroid Cancer GUIDELINES Pocket Guide is endorsed by the American Thyroid Association and reflects the latest ATA recommendations. This practical quick-reference tool contains graded recommendations for diagnosis, including immunohistochemical markers, and treatment of local, regional and metastatic disease with management algorithms and tables of chemotherapy and adjuvant/radiosensitizing regimens.  Also included are recommendations for palliative care and long-term monitoring.

  • Spiral Bound
  • 14 pages
  • 80# Diamond Silk Cover with Satin Aqueous Coating
  • 4.5″ x 7.25″
  • Key Points
  • Differential diagnosis
  • Establishing Treatment Goals
  • Locoregional Disease
    • Radiotherapy and Systemic Chemotherapy
  • Supportive Care During Active Treatment
  • Advanced Metastatic Disease
  • Palliative Care and Hospice
  • Surveillance and Long-Term Monitoring
  • Restaging of Patients with Persistent Metastatic Disease
  • Tables
    • Immunohistochemical Markers
    • Adjuvant/Radiosensitizing Chemotherapy
    • Chemotherapy Regimen
    • Residual Tumor Classification
  • Figures
    • Management of Stage IVA & IVB Disease
    • Management of Stage IVC Disease 

The ATA is the leading organization devoted to thyroid biology and to the prevention and treatment of thyroid disease through excellence in research, clinical care, education, and public health. To learn more, visit -

  • Guideline Pricing

  • Single Title
    $4.99 / year
  • Any 5 Titles
    $23.99 / year
  • Any 10 Titles
    $41.99 / year
  • Any 35 Titles
    $74.99 / year
  • All Available Titles
    $169.99 / year

To get started, log in or create your free account Create Account